Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All Insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Secondary marketplace / Trade private companies / Buy and sell Enveda Biosciences stock
Enveda Biosciences

Enveda Biosciences stock

Highest bid
$XXXX
x/xx/xx
Lowest ask
$XXXX
x/xx/xx
Last matched price
$XXXX
x/xx/xx
$--
Register to buy and sell private company shares
For more details on private stock price information, financing and valuation for Enveda Biosciences, register or log in.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

Enveda Biosciences stock price

Trade metrics

Market activity 2
Limited
Active bids
XX
Active asks
XX
Highest bid price
$ XXX.XX
Lowest ask price
$ XXX.XX
Total bids
$XXX
Total asks
$XXX
Last matched price
$ XXX.XX
xx/xx/xxxx
Last matched valuation
$ XXX.XX
xx/xx/xxxx

Price history chart

7D
1M
3M
1Y
All
Forge Price
$--
Not yet available
Forge Price valuation
$--

Actively traded Healthcare companies

Active market

The image displayed is not current and any securities shown are for illustrative purposes only.

Forge exclusive fund offerings

Fund offerings
The image displayed is not current and any securities shown are for illustrative purposes only.
Forge exclusive fund offerings
Access high-growth companies at a fixed price—for a limited time
Invest in trending companies with lower minimums
Simplify private investing through a Forge-managed single company fund

Enveda Biosciences stock FAQs

To buy and sell Enveda Biosciences stock

Can you buy Enveda Biosciences stock?

As Enveda Biosciences is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Enveda Biosciences, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge to buy private market stock on our secondary marketplace. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy Enveda Biosciences stock?

To invest in a private company like Enveda Biosciences through Forge, you must first qualify as an accredited investor. Create your account. Verify your identity and accreditation status to access Forge’s real-time marketplace.

  1. Explore opportunities. Browse companies with active bids and asks, plus data-driven pricing insights like historical trades and Forge Price™.
  2. Submit or negotiate a bid. Place a bid or engage with existing asks—self-directed and fully transparent.
  3. Complete your trade. Forge handles paperwork and approvals, with settlement typically in 45-60 days.
If you’d like additional guidance, Forge private market specialists are available to help.

Can you sell Enveda Biosciences stock?

Yes, as a shareholder, you may be able to sell your Enveda Biosciences shares through Forge’s private market platform—subject to company policies and market interest.

To get started:

  1. Create a Forge account and complete identity and ownership verification.
  2. Submit a sell order (ask) by specifying your desired price, quantity and share class.
  3. Forge will work to match your order with interested buyers in the marketplace.
  4. If a match occurs, Forge coordinates the necessary company approvals and compliance checks, including any transfer restrictions or right of first refusal (ROFR) processes Enveda Biosciences may have in place.
Please note that the ability to complete a transaction depends on Enveda Biosciences’ secondary trading policies, available demand and transaction approvals. While liquidity is not guaranteed, listing your shares on Forge allows you to signal interest and potentially connect with qualified buyers.

How to sell Enveda Biosciences stock?

  1. Create a free Forge account to access Forge’s next generation marketplace
  2. Explore potential demand for your shares and view live market interest
  3. Use proprietary pricing insights and market data to assess timing and valuation
  4. Submit an indication to sell, negotiate terms, complete the transaction and receive your payment

To learn more about Enveda Biosciences stock

Is Enveda Biosciences a public company?

No, Enveda Biosciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Enveda Biosciences’ stock price?

Enveda Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Enveda Biosciences private market stock price with Forge Data.

What is Enveda Biosciences’ stock ticker symbol?

Enveda Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Enveda Biosciences funding rounds and valuation

Total funding $346.14MM

Funding history chart

Funding round details

Funding Date Share Class Amount Raised Price Per Share Post-Money Valuation 3 Key Investors
02/27/2025 Series C $150MM $5.27 $648.97MM Baillie Gifford, Cresset Partners, Dimension Capital, Fpv, Henry R. Kravis, Kinnevik, Lingotto, Lux Capital, Premji Invest, Sanofi, The Nature Conservancy, True Ventures
Price Per Share
$5.27
Shares Outstanding
28,439,254
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Cresset Partners, Dimension Capital, Fpv, Henry R. Kravis, Kinnevik, Lingotto, Lux Capital, Premji Invest, Sanofi, The Nature Conservancy, True Ventures
06/14/2024 Series B+ $65.69MM $4.65 $377.48MM Dimension Capital, Fpv, Henry R. Kravis, Kinnevik, True Ventures, Wireframe Ventures
Price Per Share
$4.65
Shares Outstanding
14,132,527
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Dimension Capital, Fpv, Henry R. Kravis, Kinnevik, True Ventures, Wireframe Ventures
04/20/2023 Series B $74.31MM $3.94 $258.89MM Allen & Company, Amino Collective, Dimension Capital, Fpv, Hummingbird Ventures, Jazz Venture Partners, Level Ventures, Lux Capital, Possible Ventures, True Ventures, Two Sigma Ventures, Wireframe Ventures
Price Per Share
$3.94
Shares Outstanding
18,860,406
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Allen & Company, Amino Collective, Dimension Capital, Fpv, Hummingbird Ventures, Jazz Venture Partners, Level Ventures, Lux Capital, Possible Ventures, True Ventures, Two Sigma Ventures, Wireframe Ventures
04/20/2023 Series B-1 $21MM $3.15 $258.89MM Allen & Company, Amino Collective, Dimension Capital, Fpv, Hummingbird Ventures, Jazz Venture Partners, Level Ventures, Lux Capital, Possible Ventures, True Ventures, Two Sigma Ventures, Wireframe Ventures
Price Per Share
$3.15
Shares Outstanding
6,662,266
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Allen & Company, Amino Collective, Dimension Capital, Fpv, Hummingbird Ventures, Jazz Venture Partners, Level Ventures, Lux Capital, Possible Ventures, True Ventures, Two Sigma Ventures, Wireframe Ventures
06/22/2021 Series A $30.16MM $2.80 $95.67MM Catalio Capital, Chris Gibson, Hummingbird Ventures, Lifeforce Capital, Lux Capital, True Ventures, Two Sigma Ventures, Village Global, Wireframe Ventures
Price Per Share
$2.80
Shares Outstanding
10,755,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Catalio Capital, Chris Gibson, Hummingbird Ventures, Lifeforce Capital, Lux Capital, True Ventures, Two Sigma Ventures, Village Global, Wireframe Ventures
12/27/2020 Series Seed $4.1MM $0.59 $12.77MM Chris Gibson, True Ventures, Village Global, Wireframe Ventures
Price Per Share
$0.59
Shares Outstanding
6,932,114
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Gibson, True Ventures, Village Global, Wireframe Ventures
12/27/2020 Series Seed-1 $304,331.88 $0.46 $12.77MM Chris Gibson, True Ventures, Village Global, Wireframe Ventures
Price Per Share
$0.46
Shares Outstanding
662,888
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Gibson, True Ventures, Village Global, Wireframe Ventures
12/27/2020 Series Seed-2 $145,003.08 $0.44 $12.77MM Chris Gibson, True Ventures, Village Global, Wireframe Ventures
Price Per Share
$0.44
Shares Outstanding
326,878
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Gibson, True Ventures, Village Global, Wireframe Ventures
12/27/2020 Series Seed-3 $225,023.89 $0.38 $12.77MM Chris Gibson, True Ventures, Village Global, Wireframe Ventures
Price Per Share
$0.38
Shares Outstanding
588,144
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Gibson, True Ventures, Village Global, Wireframe Ventures
12/27/2020 Series Seed-4 $56,759.77 $0.19 $12.77MM Chris Gibson, True Ventures, Village Global, Wireframe Ventures
Price Per Share
$0.19
Shares Outstanding
291,824
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Gibson, True Ventures, Village Global, Wireframe Ventures
12/27/2020 Series Seed-5 $150,042.94 $0.16 $12.77MM Chris Gibson, True Ventures, Village Global, Wireframe Ventures
Price Per Share
$0.16
Shares Outstanding
914,896
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Gibson, True Ventures, Village Global, Wireframe Ventures

Company details

Enveda Biosciences is a drug discovery platform focusing on natural biological activity as a means of development. Their current pipeline includes pain and topical dermatology areas. Enveda Biosciences was founded in 2019 by Viswa Colluru Ph.D. and Pieter Dorrestein and is headquartered in Boulder, CO.
Founded
2019
Headquarters
Boulder, CO, United States
Leadership
Viswa Colluru
Founder & Chief Executive Officer
August Allen
Chief Technology Officer
Dan Wee
Chief of Staff
Hannah Gordon
Chief Product Officer
Robert Buckley
Chief People Officer
Joe Rokicki
Founding Fellow
Sotirios Karanthanasis
Founding Fellow
Board
Harsh Patel
Wireframe Ventures
Shaquille Vayda
Lux Capital
Pegah Ebrahimi
FPV Ventures
Zavain Dar
Recursion Pharmaceuticals

Enveda Biosciences investors also invested in these private compaies

Enveda Biosciences news and media highlights

Enveda Biosciences raises $130M to advance AI-driven drug discovery from natural compounds

Enveda Biosciences Inc., a biotechnology company that leverages artificial intelligence to develop new medicines, announced that it has raised $130 million in new funding.

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

In a series B funding round led by Premji Invest, Lingotto Investment Fund, Microsoft, and The Nature Conservancy Enveda raised $55 million.

Enveda’s Matured Platform Drives Toward Three INDs in 2023

Since its launch in 2019, Enveda Biosciences has raised $124 million to advance its pipeline of nature-based small molecules targeting difficult therapeutic problems, most recently closing a Series B round in the midst of a stingy financing environment.

Enveda Biosciences appoints industry leader Mark Deeg, M.D., Ph.D., as Chief Medical Officer

Enveda Biosciences today announced the appointment of Mark Deeg, M.D., Ph.D., as the company’s Chief Medical Officer. Dr. Deeg is a medical and pharmaceutical leader with broad experience developing drugs and digital therapeutics at companies from biopharma startups to pharmaceutical giants like Eli Lilly & Co., where he spent more than a decade.
Browse More Insights

Other companies like Enveda Biosciences in the Healthcare Software sector

Sector: Healthcare
Subsector: Healthcare Software
Trade Metrics Last Funding Round
Company Forge Price Last Matched Price Share Class Post-Money Valuation 3 Price Per Share Amount Raised
AbridgeAbridge--$xx.xxSeries E$5.3B$158.48$300MM
Ambience HealthcareAmbience Healthcare--$xx.xxSeries C$1.24B$37.98$210MM
BenchlingBenchling--$xx.xxSeries F$6.1B$32.70$95MM
CommureCommure--$xx.xxSeries D-2$5.83B$95.45$8.85MM
Hippocratic AIHippocratic AI--$xx.xxSeries B$1.64B$13.42$141MM
Insilico MedicineInsilico Medicine--$xx.xx--------
OpenEvidenceOpenEvidence--$xx.xxSeries B-1$3.5B$150.87$30MM
PromptPrompt--$xx.xxSeries B$929.95MM$248.60$206MM
Rad AIRad AI--$xx.xxSeries C$527.53MM$22.51$80.9MM
Viz.aiViz.ai--$xx.xxSeries D$1.28B$6.35$120MM

Forge is your trusted partner to buy and sell Enveda Biosciences stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Updated on: Jul 16, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Most active companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.